Cost-effectiveness (C-E) of oral ibandronate compared with intravenous (iv) zoledronic acid or iv generic pamidronate in patients with metastatic bone disease from breast cancer in the UK

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Author(s): De Cock E, Hutton J, Body JJ, Canney P, Verrill M, Neary M, Lewis G

Publication type: Conference Proceedings (inc. Abstract)

Publication status: Published

Conference Name: Cancer Treatment Reviews: 5th International Conference on Cancer Induced Bone Disease (CIBD)

Year of Conference: 2005

Pages: S47-S48 abstract no. 88

ISSN: 0305-7372

Publisher: W.B. Saunders Co. Ltd.

Library holdings: Search Newcastle University Library for this item

ISBN: 15321967

ePrints